The Market Online - At The Bell

Join our daily newsletter At The Bell to receive exclusive market insights

  • Genetic Technologies (GTG) inks a deal to buy UK-based DNA testing company AffinityDNA for £555,000 (A$985,000)
  • GTG will pay 50 per cent of the cost paid upfront, with the remaining 50 per cent to be paid a year after subject to the financial success of the new business
  • This marks GTG’s second acquisition in 12 months after the company purchased EasyDNA in July 2021 for $5.4 million
  • GTG shares were sitting flat at 0.3 cents as of 2:36 pm AEDT

Genetic Technologies (GTG) has inked a deal to buy UK-based DNA testing company AffinityDNA for £555,000 (A$985,000).

Genetic will pay 50 per cent of the price upfront, with the remaining 50 per cent to be paid on the anniversary of the deal’s completion subject to the AffinityDNA businesses achieving certain financial performance parameters.

The agreement will see GTG acquire the brand and distribution rights of Affinity, which the company said would further build its direct-to-consumer offerings and lifestyle division.

This comes after the company acquired EasyDNA in July 2021 for $5.4 million — making the AffinityDNA deal the second acquisition for GTG within the last 12 months.

GTG says the AffinityDNA buyout would “provide an incremental established revenue base for GTG’s future growth”, particularly as AffinityDNA’s revenue had seen substantial growth over the last two years.

AffinityDNA sells DIY DNA test kits to members of the public for confirmation on things like paternity. The tests are conducted via a mouth swab before being sent to an external laboratory partner. Results are then sent to the customer via email.

GTG Chief Executive Officer Simon Morriss said the acquisition was an “excellent strategic fit” for the company, supporting its ongoing expansion of testing across its target markets.

“We are looking forward to working closely with the AffinityDNA team to capitalise on our commercial synergies,” Mr Morriss said.

There will be no changes to the existing employees at AffinityDNA, with key management to be retained in a consulting role.

GTG shares are sitting flat today at 0.3 cents as of 2:36 pm AEDT.

GTG by the numbers
More From The Market Online

Week 17 Wrap: BHP-Anglo deal helps push down ASX; US data of concern but AI bulls happy

The big thematics and headlines that drove the ASX this week, plus, the headlines I think…
The Market Online Video

Market Close: ASX signs off on a sigh with all sectors red-lining

The ASX200 finished 1.3 per cent down with every sector in the red and Industrials and Real Estate brittle and bruised as bot…
The Market Online Video

Market Update: ASX on red alert with all sectors below the surface

The ASX200 is trading down around 1.1% with all eleven sectors in the red. Real-estate has…

ResMed spikes on robust results and global growth spurt

ResMed shares have climbed following the release of the company's strong Third Quarter FY2024 results.